Document is current
Any future updates will be listed below
-
Authors
Badia-i-Mompel, Pau https://orcid.org/0000-0002-1004-3923
Wessels, Lorna https://orcid.org/0009-0004-4198-7654
Müller-Dott, Sophia https://orcid.org/0000-0002-9710-1865
Trimbour, Rémi https://orcid.org/0000-0001-8770-8412
Ramirez Flores, Ricardo O. https://orcid.org/0000-0003-0087-371X
Argelaguet, Ricard https://orcid.org/0000-0003-3199-3722
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
- License Information
-
More Information
Article History
Accepted: 12 May 2023
First Online: 26 June 2023
Competing interests
: J.S.-R. reports funding from GSK, Pfizer and Sanofi, and consultant fees from Travere Therapeutics, Stadapharm and Astex Pharmaceutical. R.A. is an employee of Altos Labs. The other authors declare no competing interests.
